Sarepta Therapeutics Moves From Seattle to Boston for the Talent
Just when it
looked like Seattle might be getting another emerging biotech company in
Sarepta Therapeutics, it has picked up and moved east. Sarepta (NASDAQ: SRPT),
the company formerly known as AVI Biopharma, has moved its headquarters from
Bothell, WA, to Cambridge, MA, CEO Chris Garabedian said yesterday in a phone
interview. The company currently has about 110 employees, with about 40 in
Bothell and the rest in Cambridge and Corvallis, OR. Sarepta hasn’t made a
final decision about what to do with its Bothell site, but Garabedian says the
company’s lease expires near the end of 2012 and Bothell staff is being
evaluated and may be offered transfers to one of the two other locations.
Click Here For More Information:
Are you looking to save money on Pharmaceutical Process Equipment? Shop SSLLC.com for 40-80% off our preowned / used instruments.
